[1] A. T. McLellan, “Have we evaluated addiction treatment correctly? Implications from a chronic care perspective,” Addiction, vol. 97, no. 3, pp. 249–252, 2002.
[2] A. T. McLellan, J. R. McKay, R. Forman, J. Cacciola, and J. Kemp, “Reconsidering the evaluation of addiction treatment: from retrospective follow‐up to concurrent recovery monitoring,” Addiction, vol. 100, no. 4, pp. 447–458, 2005.
[3] W. White, Recovery management and recovery-oriented systems of care, vol. 6. Chicago: Great Lakes Addiction Technology Transfer Center, Northeast …, 2008.
[4] G. De Leon, The therapeutic community: Theory, model, and method. Springer Publishing Company, 2000.
[5] G. Adshead, “Security and the social mind: Attachment and therapeutic communities,” Ther. Communities Int. J. Ther. Communities, 2015.
[6] D. Veale, P. Gilbert, J. Wheatley, and I. Naismith, “A new therapeutic community: Development of a compassion‐focussed and contextual behavioural environment,” Clin. Psychol. Psychother., vol. 22, no. 4, pp. 285–303, 2015.
[7] L. Magor-blatch, N. Bhullar, B. Thomson, and E. Thorsteinsson, “A systematic review of studies examining effectiveness of therapeutic communities,” 2014.
[8] P. K. Staiger, P. Liknaitzky, A. J. Lake, and S. Gruenert, “Longitudinal Substance Use and Biopsychosocial Outcomes Following Therapeutic Community Treatment for Substance Dependence,” J. Clin. Med., vol. 9, no. 1, p. 118, 2020.
[9] W. Vanderplasschen et al., “Therapeutic communities for addictions : a review of their effectiveness from a recovery- oriented perspective ( Greek version ). Therapeutic Communities for Addictions : A Review of Their Effectiveness from a Recovery-Oriented Perspective,” no. September 2016, 2014.
[10] M. Malivert, “Effectiveness of Therapeutic Communities :,” pp. 1–11, 2012.
[11] R. M. Etheridge, S. G. Craddock, G. H. Dunteman, and R. L. Hubbard, “Treatment services in two national studies of community-based drug abuse treatment programs,” J. Subst. Abuse, vol. 7, no. 1, pp. 9–26, 1995.
[12] M. Gossop, J. Marsden, D. Stewart, and A. Rolfe, “Treatment retention and 1 year outcomes for residential programmes in England,” vol. 57, pp. 89–98, 1999.
[13] D. D. Simpson and S. B. Sells, “Effectiveness of treatment for drug abuse: An overview of the DARP research program,” Adv. Alcohol Subst. Abuse, vol. 2, no. 1, pp. 7–29, 1982.
[14] A. Jones et al., “The Drug Treatment Outcomes Research Study (DTORS): Final outcomes report,” Londres Home Off. Recuper. http//www. dtors. org. uk/reports/DTORS_Final_Main. pdf, 2009.
[15] J. R. McKay, “Continuing care research: What we have learned and where we are going,” J. Subst. Abuse Treat., vol. 36, no. 2, pp. 131–145, 2009.
[16] Y.-I. Hser, M. D. Anglin, and B. Fletcher, “Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction,” J. Subst. Abuse Treat., vol. 15, no. 6, pp. 513–523, 1998.
[17] R. L. Hubbard, J. V Rachal, and S. G. Craddock, “Treatment outcome prospective study (TOPS): client characteristics before, during, and after treatment” Washingt. NIDA, 1984.
[18] S. Darke, J. Ross, K. L. Mills, A. Williamson, A. Havard, and M. Teesson, “Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS),” Addict. Behav., vol. 32, no. 9, pp. 1897–1906, 2007.
[19] B. J. Rounsaville, M. M. Weissman, K. Crits-Christoph, C. Wilber, and H. Kleber, “Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome,” Arch. Gen. Psychiatry, vol. 39, no. 2, pp. 151–156, 1982.
[20] R. P. Mattick, S. O’Brien, and J. Dodding, Outcome evaluation of the Woolshed Program. National Drug and Alcohol Research Centre, University of New South Wales, 1998.
[21] R. H. Coombs, “Back on the streets: Therapeutic communities’ impact upon drug users,” Am. J. Drug Alcohol Abuse, vol. 8, no. 2, pp. 185–201, 1981.
[22] M. L. Hiller, K. Knight, and D. D. Simpson, “Prison‐based substance abuse treatment, residential aftercare and recidivism,” Addiction, vol. 94, no. 6, pp. 833–842, 1999.
[23] N. Vidjak, “Treating heroin addiction: Comparison of methadone therapy, hospital therapy without methadone, and therapeutic community,” Croat. Med. J., vol. 44, no. 1, pp. 59–64, 2002.
[24] S. Darke, G. Campbell, and G. Popple, “Retention, early dropout and treatment completion among therapeutic community admissions,” Drug Alcohol Rev., vol. 31, no. 1, pp. 64–71, 2012.
[25] C. Perryman, G. A. Dingle, C. Perryman, and G. Dingle, “A systematic review of the methodologies used in research related to adult drug and alcohol rehabilitation in therapeutic communities,” no. September 2016, 2015.
[26] D. D. Simpson, G. W. Joe, K. M. Broome, M. L. Hiller, K. Knight, and G. A. Rowan-Szal, “Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS).,” Psychol. Addict. Behav., vol. 11, no. 4, p. 279, 1997.
[27] N. D. Volkow, Principles of drug addiction treatment: A research-based guide, vol. 12, no. 4180. DIANE Publishing, 2011.
[28] J. J. López-goñi, J. Fernández-, C. Illescas, and N. Landa, “Determining socio-demographic predictors of treatment dropout : results in a therapeutic community,” no. 2006, pp. 374–378, 2008.
[29] K. J. Brower, F. C. Blow, E. M. Hill, and S. A. Mudd, “Treatment outcome of alcoholics with and without cocaine disorders,” Alcohol. Clin. Exp. Res., vol. 18, no. 3, pp. 734–739, 1994.
[30] R. E. Claus, L. R. Kindleberger, and M. C. Dugan, “Predictors of attrition in a longitudinal study of substance abusers,” J. Psychoactive Drugs, vol. 34, no. 1, pp. 69–74, 2002.
[31] R. R. Gainey, E. A. Wells, J. D. Hawkins, and R. F. Catalano, “Predicting treatment retention among cocaine users,” Int. J. Addict., vol. 28, no. 6, pp. 487–505, 1993.
[32] J. R. McKAY, A. T. McLELLAN, A. I. Alterman, J. S. Cacciola, M. J. Rutherford, and C. P. O’Brien, “Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse.,” J. Stud. Alcohol, vol. 59, no. 2, pp. 152–162, 1998.
[33] N. Sadir, M. Shojaei, K. Moadab, R. Abbasi, and A. Bahrampour, “Outcome Evaluation of Therapeutic Community Model in Iran,” vol. 1, no. 2, pp. 131–135, 2013.
[34] W. N. Welsh and P. N. McGrain, “Predictors of therapeutic engagement in prison-based drug treatment,” Drug Alcohol Depend., vol. 96, no. 3, pp. 271–280, 2008.
[35] R. T. Mulder, C. M. A. FRAMPTON, H. Peka, G. Hampton, and T. Marsters, “Predictors of 3‐month retention in a drug treatment therapeutic community,” Drug Alcohol Rev., vol. 28, no. 4, pp. 366–371, 2009.
[36] K. Knight, M. L. Hiller, K. M. Broome, and D. D. Simpson, “Legal pressure, treatment readiness, and engagement in long-term residential programs,” J. Offender Rehabil., vol. 31, no. 1–2, pp. 101–115, 2000.
[37] M. L. Hiller, K. Knight, C. Leukefeld, and D. D. Simpson, “Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment,” Crim. Justice Behav., vol. 29, no. 1, pp. 56–75, 2002.
[38] P. S. Meier and D. Best, “Programme factors that influence completion of residential treatment,” no. July, pp. 349–355, 2006.
[39] A. T. Alshomrani, A. T. Khoja, S. F. Alseraihah, and M. A. Mahmoud, “Drug use patterns and demographic correlations of residents of Saudi therapeutic communities for addiction,” J. Taibah Univ. Med. Sci., vol. 12, no. 4, pp. 304–312, 2017.
[40] A. T. Alshomrani, “Saudi addiction therapeutic communities: Are they implementing the essential elements of addiction therapeutic communities?,” Neurosciences, vol. 21, no. 3, pp. 227–231, 2016.
[41] P. B. Practice, “Towards Better Practice in Therapeutic Communities[1] P. B. Practice, ‘Towards Better Practice in Therapeutic Communities.’”
[42] J. Keen, P. Oliver, G. Rowse, and N. Mathers, “Residential rehabilitation for drug users: a review of 13 months’ intake to a therapeutic community,” Fam. Pract., vol. 18, no. 5, pp. 545–548, 2001.
[43] M. Maglione, B. Chao, and D. Anglin, “Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994–1997,” Addict. Res., vol. 8, no. 1, pp. 65–79, 2000.